{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:51:13Z","timestamp":1785775873991,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T00:00:00Z","timestamp":1277424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/nn.2565","type":"journal-article","created":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T14:47:01Z","timestamp":1277477221000},"page":"795-799","source":"Crossref","is-referenced-by-count":29,"title":["Therapy development in spinal muscular atrophy"],"prefix":"10.1038","volume":"13","author":[{"given":"Michael","family":"Sendtner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,25]]},"reference":[{"key":"BFnn2565_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11910-009-0030-9","volume":"9","author":"PN Valdmanis","year":"2009","unstructured":"Valdmanis, P.N., Daoud, H., Dion, P.A. & Rouleau, G.A. Recent advances in the genetics of amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep. 9, 198\u2013205 (2009).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnn2565_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.bbadis.2006.08.001","volume":"1762","author":"CL Simpson","year":"2006","unstructured":"Simpson, C.L. & Al-Chalabi, A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim. Biophys. Acta 1762, 973\u2013985 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnn2565_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"TO Crawford","year":"1996","unstructured":"Crawford, T.O. & Pardo, C.A. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3, 97\u2013110 (1996).","journal-title":"Neurobiol. Dis."},{"key":"BFnn2565_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes, A.H. & Beattie, C.E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597\u2013609 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnn2565_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/hmg\/11.1.93","volume":"11","author":"W Rossoll","year":"2002","unstructured":"Rossoll, W. et al. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp\/hnRNP-Q: a role for Smn in RNA processing in motor axons? Hum. Mol. Genet. 11, 93\u2013105 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth, B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat. 15, 228\u2013237 (2000).","journal-title":"Hum. Mutat."},{"key":"BFnn2565_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni, L. & Krainer, A.R. Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30, 377\u2013384 (2002).","journal-title":"Nat. Genet."},{"key":"BFnn2565_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima, T. & Manley, J.L. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet. 34, 460\u2013463 (2003).","journal-title":"Nat. Genet."},{"key":"BFnn2565_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","volume":"120","author":"VB Mattis","year":"2006","unstructured":"Mattis, V.B. et al. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts. Hum. Genet. 120, 589\u2013601 (2006).","journal-title":"Hum. Genet."},{"key":"BFnn2565_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.1884910","volume":"24","author":"S Cho","year":"2010","unstructured":"Cho, S. & Dreyfuss, G. A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 24, 438\u2013442 (2010).","journal-title":"Genes Dev."},{"key":"BFnn2565_CR11","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank, B. et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl. Acad. Sci. USA 94, 9920\u20139925 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2565_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","volume":"9","author":"S Jablonka","year":"2000","unstructured":"Jablonka, S., Schrank, B., Kralewski, M., Rossoll, W. & Sendtner, M. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum. Mol. Genet. 9, 341\u2013346 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani, U.R. et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn\u2212\/\u2212 mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333\u2013339 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.200304128","volume":"163","author":"W Rossoll","year":"2003","unstructured":"Rossoll, W. et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J. Cell Biol. 163, 801\u2013812 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnn2565_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.200303168","volume":"162","author":"ML McWhorter","year":"2003","unstructured":"McWhorter, M.L., Monani, U.R., Burghes, A.H. & Beattie, C.E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919\u2013931 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnn2565_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","volume":"29","author":"L Kong","year":"2009","unstructured":"Kong, L. et al. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 29, 842\u2013851 (2009).","journal-title":"J. Neurosci."},{"key":"BFnn2565_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.200703187","volume":"179","author":"S Jablonka","year":"2007","unstructured":"Jablonka, S., Beck, M., Lechner, B.D., Mayer, C. & Sendtner, M. Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy. J. Cell Biol. 179, 139\u2013149 (2007).","journal-title":"J. Cell Biol."},{"key":"BFnn2565_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le, T.T. et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14, 845\u2013857 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/ejhg.2008.41","volume":"16","author":"M Jedrzejowska","year":"2008","unstructured":"Jedrzejowska, M. et al. Unaffected patients with a homozygous absence of the SMN1 gene. Eur. J. Hum. Genet. 16, 930\u2013934 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnn2565_CR20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","volume":"14","author":"J Jarecki","year":"2005","unstructured":"Jarecki, J. et al. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum. Mol. Genet. 14, 2003\u20132018 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0065-230X(04)91004-4","volume":"91","author":"PA Marks","year":"2004","unstructured":"Marks, P.A., Richon, V.M., Miller, T. & Kelly, W.K. Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137\u2013168 (2004).","journal-title":"Adv. Cancer Res."},{"key":"BFnn2565_CR22","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang, J.G. et al. Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98, 9808\u20139813 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2565_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner, C.J. et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann. Neurol. 54, 647\u2013654 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnn2565_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI29562","volume":"117","author":"AM Avila","year":"2007","unstructured":"Avila, A.M. et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest. 117, 659\u2013671 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnn2565_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nbd.2006.07.004","volume":"24","author":"LK Tsai","year":"2006","unstructured":"Tsai, L.K., Tsai, M.S., Lin, T.B., Hwu, W.L. & Li, H. Establishing a standardized therapeutic testing protocol for spinal muscular atrophy. Neurobiol. Dis. 24, 286\u2013295 (2006).","journal-title":"Neurobiol. Dis."},{"key":"BFnn2565_CR26","doi-asserted-by":"publisher","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","volume":"4","author":"KJ Swoboda","year":"2009","unstructured":"Swoboda, K.J. et al. Phase II open label study of valproic acid in spinal muscular atrophy. PLoS ONE 4, e5268 (2009).","journal-title":"PLoS ONE"},{"key":"BFnn2565_CR27","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1093\/hmg\/ddp313","volume":"18","author":"L Garbes","year":"2009","unstructured":"Garbes, L. et al. LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum. Mol. Genet. 18, 3645\u20133658 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/hmg\/ddp510","volume":"19","author":"ME Butchbach","year":"2010","unstructured":"Butchbach, M.E. et al. Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Hum. Mol. Genet. 19, 454\u2013467 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.nbd.2009.08.014","volume":"36","author":"K Rak","year":"2009","unstructured":"Rak, K. et al. Valproic acid blocks excitability in SMA type I mouse motor neurons. Neurobiol. Dis. 36, 477\u2013487 (2009).","journal-title":"Neurobiol. Dis."},{"key":"BFnn2565_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ejhg.2009.160","volume":"18","author":"A Artsma-Rus","year":"2010","unstructured":"Artsma-Rus, A. & van Ommen, G.J. Progress in therapeutic antisense applications for neuromuscular disorders. Eur. J. Hum. Genet. 18, 146\u2013153 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnn2565_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcb.20790","volume":"98","author":"WH Pan","year":"2006","unstructured":"Pan, W.H. & Clawson, G.A. Antisense applications for biological control. J. Cell. Biochem. 98, 14\u201335 (2006).","journal-title":"J. Cell. Biochem."},{"key":"BFnn2565_CR32","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1056\/NEJMoa073108","volume":"357","author":"JC van Deutekom","year":"2007","unstructured":"van Deutekom, J.C. et al. Local dystrophin restoration with antisense oligonucleotide PRO051. N. Engl. J. Med. 357, 2677\u20132686 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnn2565_CR33","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1126\/science.1104297","volume":"306","author":"A Goyenvalle","year":"2004","unstructured":"Goyenvalle, A. et al. Rescue of dystrophic muscle through U7 small nuclear RNA-mediated exon skipping. Science 306, 1796\u20131799 (2004).","journal-title":"Science"},{"key":"BFnn2565_CR34","first-page":"108","volume":"11","author":"B Khoo","year":"2009","unstructured":"Khoo, B. & Krainer, A.R. Splicing therapeutics in SMN2 and APOB. Curr. Opin. Mol. Ther. 11, 108\u2013115 (2009).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"BFnn2565_CR35","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/gt.2008.54","volume":"15","author":"AK Zaiss","year":"2008","unstructured":"Zaiss, A.K. & Muruve, D.A. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Ther. 15, 808\u2013816 (2008).","journal-title":"Gene Ther."},{"key":"BFnn2565_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/hmg\/ddn382","volume":"18","author":"K Meyer","year":"2009","unstructured":"Meyer, K. et al. Rescue of a severe mouse model for spinal muscular atrophy by U7 small nuclear RNA-mediated splicing modulation. Hum. Mol. Genet. 18, 546\u2013555 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnn2565_CR37","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua, Y., Vickers, T.A., Okunola, H.L., Bennett, C.F. & Krainer, A.R. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am. J. Hum. Genet. 82, 834\u2013848 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnn2565_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/nar\/gkl1050","volume":"35","author":"NN Singh","year":"2007","unstructured":"Singh, N.N., Singh, R.N. & Androphy, E.J. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res. 35, 371\u2013389 (2007).","journal-title":"Nucleic Acids Res."},{"key":"BFnn2565_CR39","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"Y Hua","year":"2007","unstructured":"Hua, Y., Vickers, T.A., Baker, B.F., Bennett, C.F. & Krainer, A.R. Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol. 5, e73 (2007).","journal-title":"PLoS Biol."},{"key":"BFnn2565_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph, G.S. et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11, 429\u2013433 (2005).","journal-title":"Nat. Med."},{"key":"BFnn2565_CR41","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1172\/JCI22922","volume":"114","author":"M Azzouz","year":"2004","unstructured":"Azzouz, M. et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J. Clin. Invest. 114, 1726\u20131731 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnn2565_CR42","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2008.73","volume":"16","author":"C Towne","year":"2008","unstructured":"Towne, C., Raoul, C., Schneider, B.L. & Aebischer, P. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol. Ther. 16, 1018\u20131025 (2008).","journal-title":"Mol. Ther."},{"key":"BFnn2565_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust, K.D. et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol. 28, 271\u2013274 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnn2565_CR44","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI41615","volume":"120","author":"MA Passini","year":"2010","unstructured":"Passini, M.A. et al. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J. Clin. Invest. 120, 1253\u20131264 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnn2565_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/gt.2009.119","volume":"17","author":"C Towne","year":"2010","unstructured":"Towne, C., Schneider, B.L., Kieran, D., Redmond, D.E. Jr. & Aebischer, P. Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. Gene Ther. 17, 141\u2013146 (2010).","journal-title":"Gene Ther."},{"key":"BFnn2565_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K.D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"issue":"suppl.","key":"BFnn2565_CR47","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nn938","volume":"5","author":"H Thoenen","year":"2002","unstructured":"Thoenen, H. & Sendtner, M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5 (suppl.), 1046\u20131050 (2002).","journal-title":"Nat. Neurosci."},{"key":"BFnn2565_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/bies.20092","volume":"26","author":"E Storkebaum","year":"2004","unstructured":"Storkebaum, E., Lambrechts, D. & Carmeliet, P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26, 943\u2013954 (2004).","journal-title":"Bioessays"},{"key":"BFnn2565_CR49","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1126\/science.1158799","volume":"321","author":"JT Dimos","year":"2008","unstructured":"Dimos, J.T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218\u20131221 (2008).","journal-title":"Science"},{"key":"BFnn2565_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert, A.D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277\u2013280 (2009).","journal-title":"Nature"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn.2565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.2565","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.2565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:05:54Z","timestamp":1684454754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn.2565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,25]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFnn2565"],"URL":"https:\/\/doi.org\/10.1038\/nn.2565","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,25]]}}}